The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match
Open Access
- 23 October 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 24 (1), 1-3
- https://doi.org/10.1634/theoncologist.2017-0519
Abstract
This commentary evaluates the immune‐genomic connection.Keywords
This publication has 10 references indexed in Scilit:
- Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid TumorsJAMA Oncology, 2018
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaThe New England Journal of Medicine, 2017
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersMolecular Cancer Therapeutics, 2017
- Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth RateClinical Cancer Research, 2017
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Mutations Associated with Acquired Resistance to PD-1 Blockade in MelanomaThe New England Journal of Medicine, 2016
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeJournal of Clinical Oncology, 2016
- PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyThe New England Journal of Medicine, 2015
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumorsJournal for ImmunoTherapy of Cancer, 2013
- A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.1998